Recent research conducted by investigators at NYU Langone Health analyzed prostate tissue collected from men undergoing surgery for prostate cancer. The researchers detected microplastics within prostate tissue and observed that cancerous tumors contained higher concentrations of plastic particles than nearby non-cancerous tissue. Tumor samples averaged roughly 40 micrograms of plastic per gram of tissue, compared with about 16 micrograms per gram in normal prostate tissue. Microplastic fragments were identified in the majority of patients examined. This represents one of the first studies directly comparing plastic accumulation between malignant and healthy prostate tissue.

The key point is that the study identified an association, not proof that microplastics cause prostate cancer.

Earlier scientific work had already demonstrated the presence of microplastics in human prostate tissue. Studies published in 2024 confirmed detection of plastic particles in prostate samples and began exploring whether environmental exposures could influence urologic health. The newer research builds on these earlier findings by comparing cancerous and non-cancerous tissues within the same patients.

At present, scientists do not conclude that microplastics cause prostate cancer. Researchers emphasize that the evidence only shows that microplastics are present and may accumulate differently in diseased tissue. Microplastics enter the human body through food, drinking water, and inhaled air, and they have now been detected in multiple organs. Laboratory experiments suggest that certain microplastics can trigger inflammation, oxidative stress, and cellular signaling changes that are biologically linked to cancer processes, but these mechanisms have not yet been proven to operate in real human disease.

Several explanations are being investigated to understand why tumors might contain higher plastic concentrations. Cancer tissue often has abnormal blood vessels that allow particles to enter more easily, and tumors frequently attract inflammatory activity that may trap foreign particles. Another possibility is that plastics act as carriers for chemical additives or pollutants, which could influence surrounding cells. It is also possible that tumors accumulate particles simply because cancer alters tissue structure, meaning microplastics may be a consequence rather than a cause of disease.

Scientists also note important limitations. Detection methods are extremely sensitive, and preventing contamination during analysis is challenging. Some researchers have questioned whether all reported measurements accurately reflect internal exposure levels. Because the field is still new, results are being interpreted cautiously while methods continue to improve.

The current scientific consensus is that microplastics have been detected in prostate cancer tissue and may appear at higher levels in tumors, but there is no definitive evidence showing they initiate or cause prostate cancer. Researchers consider this an early signal that warrants further investigation rather than a confirmed causal relationship.

This line of research is part of a broader shift in environmental health science, where microplastics are increasingly studied as a potential long-term exposure similar to air pollution or other environmental contaminants that may influence chronic disease risk over time.